Development
Dolby Laboratories, Inc.
DLB
$71.98
-$0.36-0.50%
NYSE
| 12/29/2023 | 09/29/2023 | 06/30/2023 | 03/31/2023 | 12/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 315.57M | 290.56M | 298.37M | 375.89M | 334.92M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 315.57M | 290.56M | 298.37M | 375.89M | 334.92M |
| Cost of Revenue | 32.06M | 35.55M | 41.52M | 41.05M | 34.45M |
| Gross Profit | 283.51M | 255.01M | 256.86M | 334.84M | 300.47M |
| SG&A Expenses | 144.17M | 161.28M | 154.75M | 157.63M | 142.18M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 243.26M | 267.26M | 264.96M | 266.63M | 241.08M |
| Operating Income | 72.31M | 23.30M | 33.41M | 109.26M | 93.84M |
| Income Before Tax | 80.83M | 9.03M | 23.76M | 117.28M | 99.98M |
| Income Tax Expenses | 13.25M | -875.00K | 7.35M | 21.40M | 20.53M |
| Earnings from Continuing Operations | 67.58M | 9.91M | 16.41M | 95.88M | 79.45M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -600.00K | -722.00K | -6.00K | -187.00K | -73.00K |
| Net Income | 66.98M | 9.19M | 16.40M | 95.70M | 79.38M |
| EBIT | 72.31M | 23.30M | 33.41M | 109.26M | 93.84M |
| EBITDA | 90.18M | 44.43M | 54.45M | 130.49M | 113.00M |
| EPS Basic | 0.70 | 0.10 | 0.17 | 1.00 | 0.83 |
| Normalized Basic EPS | 0.56 | 0.22 | 0.27 | 0.76 | 0.65 |
| EPS Diluted | 0.69 | 0.09 | 0.17 | 0.98 | 0.82 |
| Normalized Diluted EPS | 0.55 | 0.22 | 0.26 | 0.75 | 0.64 |
| Average Basic Shares Outstanding | 95.38M | 95.70M | 95.66M | 95.82M | 95.91M |
| Average Diluted Shares Outstanding | 97.44M | 97.68M | 97.46M | 97.30M | 97.05M |
| Dividend Per Share | 0.30 | 0.30 | 0.27 | 0.27 | 0.27 |
| Payout Ratio | 42.63% | 281.11% | 157.59% | 27.04% | 32.59% |